Literature DB >> 8761224

Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study.

V A Arason1, K G Kristinsson, J A Sigurdsson, G Stefánsdóttir, S Mölstad, S Gudmundsson.   

Abstract

OBJECTIVE: To study the correlation of antimicrobial consumption with the carriage rate of penicillin resistant and multiresistant pneumococci in children.
DESIGN: Cross sectional and analytical prevalence study.
SETTING: Five different communities in Iceland. MAIN OUTCOME MEASURE: Prevalence of nasopharyngeal carriage of penicillin resistant pneumococci in children aged under 7 years in relation to antibiotic use as determined by information from parents, patient's records, and total sales of antimicrobials from local pharmacies in four study areas.
RESULTS: Total antimicrobial sales for children (6223 prescriptions) among the four areas for which data were available ranged from 9.6 to 23.2 defined daily doses per 1000 children daily (1.1 to 2.6 courses yearly per child). Children under 2 consumed twice as much as 2-6 year olds (20.5 v 10.9 defined daily doses per 1000 children daily). Nasopharyngeal specimens were obtained from 919 children, representing 15-38% of the peer population groups in the different areas. Pneumococci were carried by 484 (52.7%) of the children, 47 (9.7%) of the isolates being resistant to penicillin or multiresistant. By multivariate analysis age (< 2 years), area (highest antimicrobial consumption), and individual use of antimicrobials significantly influenced the odds of carrying penicillin resistant pneumococci. By univariate analysis, recent antimicrobial use (two to seven weeks) and use of co-trimoxazole were also significantly associated with carriage of penicillin resistant pneumococci.
CONCLUSIONS: Antimicrobial use, with regard to both individual use and total antimicrobial consumption in the community, is strongly associated with nasopharyngeal carriage of penicillin resistant pneumococci in children. Control measures to reduce the prevalence of penicillin resistant pneumococci should include reducing the use of antimicrobials in community health care.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761224      PMCID: PMC2351797          DOI: 10.1136/bmj.313.7054.387

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  19 in total

1.  Resistance to erythromycin in group A streptococci.

Authors:  H Seppälä; A Nissinen; H Järvinen; S Huovinen; T Henriksson; E Herva; S E Holm; M Jahkola; M L Katila; T Klaukka
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

2.  Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary.

Authors:  A Marton; M Gulyas; R Munoz; A Tomasz
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

Review 3.  New mechanisms of bacterial resistance to antimicrobial agents.

Authors:  G A Jacoby; G L Archer
Journal:  N Engl J Med       Date:  1991-02-28       Impact factor: 91.245

Review 4.  Epidemiology of penicillin resistant pneumococci in Iceland.

Authors:  K G Kristinsson
Journal:  Microb Drug Resist       Date:  1995       Impact factor: 3.431

5.  Screening pneumococci for penicillin resistance.

Authors:  J M Swenson; B C Hill; C Thornsberry
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

6.  Some aspects of the pneumococcal carrier state.

Authors:  R Austrian
Journal:  J Antimicrob Chemother       Date:  1986-07       Impact factor: 5.790

7.  Use of antibiotics in general practice in Denmark. Prescribed daily dose, duration of treatment and number of treatments in general practice.

Authors:  F Bro; C E Mabeck
Journal:  Scand J Prim Health Care       Date:  1986-05       Impact factor: 2.581

Review 8.  Antimicrobial resistance in hospital organisms and its relation to antibiotic use.

Authors:  J E McGowan
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec

9.  A rapid slide-agglutination method for typing pneumococci by means of specific antibody adsorbed to protein A-containing staphylococci.

Authors:  G Kronvall
Journal:  J Med Microbiol       Date:  1973-05       Impact factor: 2.472

10.  Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life.

Authors:  B M Gray; G M Converse; H C Dillon
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

View more
  101 in total

1.  Influence of prescription patterns in general practice on anti-microbial resistance in Norway.

Authors:  M Lindbaek; D Berild; J Straand; P Hjortdahl
Journal:  Br J Gen Pract       Date:  1999-06       Impact factor: 5.386

2.  Role of global surveillance in combating bacterial resistance.

Authors:  A Marchese; G C Schito
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions.

Authors:  M Lipsitch; C T Bergstrom; B R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

4.  Partnership with patients. Treat patients as you would like to be treated yourself.

Authors:  O P Bleker
Journal:  BMJ       Date:  2000-01-08

5.  Controversies in management: should general practitioners perform diagnostic tests on patients before prescribing antibiotics?

Authors:  H J Kolmos; P Little
Journal:  BMJ       Date:  1999-03-20

6.  Managing upper respiratory tract infections: practice without evidence.

Authors:  E Lautenbach; J P Metlay
Journal:  J Gen Intern Med       Date:  1999-03       Impact factor: 5.128

7.  Current Concepts of Therapy for Otitis Media.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

Review 8.  Antimicrobial resistance--pharmacological solutions.

Authors:  E Rubinstein
Journal:  Infection       Date:  1999       Impact factor: 3.553

9.  A matter of perspective.

Authors:  M W Enkin; A R Jadad
Journal:  CMAJ       Date:  2000-06-27       Impact factor: 8.262

10.  Length of penicillin treatment of streptococcal infections. Is seven days of treatment as effective as 10 days.

Authors:  D Michaeli
Journal:  BMJ       Date:  2000-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.